DUCREUX, M., G. K. ABOU-ALFA, T. BEKAII-SAAB, J. BERLIN, A. CERVANTES, T. DE BAERE, C. ENG, P. GALLE, S. GILL, T. GRUENBERGER, K. HAUSTERMANS, A. LAMARCA, P. LAURENT-PUIG, J. M. LLOVET, F. LORDICK, T. MACARULLA, D. MUKHERJI, K. MURO, Radka LORDICK OBERMANNOVÁ, J-M. CONNOR, E. M. REILLY, P. OSTERLUND, P. PHILIP, G. PRAGER, E. RUIZ-GARCIA, B. SANGRO, T. SEUFFERLEIN, J. TABERNERO, C. VERSLYPE, H. WASAN and E. VAN CUTSEM. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022. ESMO OPEN. AMSTERDAM: ELSEVIER, 2023, vol. 8, No 3, p. 1-11. ISSN 2059-7029. Available from: https://dx.doi.org/10.1016/j.esmoop.2023.101567.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
Authors DUCREUX, M., G. K. ABOU-ALFA, T. BEKAII-SAAB, J. BERLIN, A. CERVANTES, T. DE BAERE, C. ENG, P. GALLE, S. GILL, T. GRUENBERGER, K. HAUSTERMANS, A. LAMARCA, P. LAURENT-PUIG, J. M. LLOVET, F. LORDICK, T. MACARULLA, D. MUKHERJI, K. MURO, Radka LORDICK OBERMANNOVÁ (203 Czech Republic, belonging to the institution), J-M. CONNOR, E. M. REILLY, P. OSTERLUND, P. PHILIP, G. PRAGER, E. RUIZ-GARCIA, B. SANGRO, T. SEUFFERLEIN, J. TABERNERO, C. VERSLYPE, H. WASAN and E. VAN CUTSEM.
Edition ESMO OPEN, AMSTERDAM, ELSEVIER, 2023, 2059-7029.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 7.300 in 2022
RIV identification code RIV/00216224:14110/23:00133415
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1016/j.esmoop.2023.101567
UT WoS 001045033500001
Keywords in English hepatocellular carcinoma; liver transplantation; chemoembolisation; immunotherapy; radioembolisation
Tags 14110811, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 2/2/2024 10:59.
Abstract
This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options.
PrintDisplayed: 30/9/2024 05:34